ONTRAK INC (OTRK)
US6833733024 - Common Stock
OTRK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 109 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of OTRK have multiple concerns. OTRK is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year OTRK has reported negative net income.
OTRK had a negative operating cash flow in the past year.
In the past 5 years OTRK always reported negative net income.
In the past 5 years OTRK always reported negative operating cash flow.
1.2 Ratios
OTRK has a Return On Assets of -159.29%. This is amonst the worse of the industry: OTRK underperforms 95.37% of its industry peers.
OTRK's Return On Equity of -311.45% is on the low side compared to the rest of the industry. OTRK is outperformed by 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -159.29% | ||
| ROE | -311.45% | ||
| ROIC | N/A |
ROA(3y)-156.54%
ROA(5y)-118.81%
ROE(3y)-473.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OTRK's Gross Margin of 64.00% is amongst the best of the industry. OTRK outperforms 87.04% of its industry peers.
OTRK's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for OTRK so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.4%
GM growth 5Y20.89%
2. Health
2.1 Basic Checks
OTRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OTRK has been reduced compared to 1 year ago.
Compared to 5 years ago, OTRK has less shares outstanding
The debt/assets ratio for OTRK has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -32.47, we must say that OTRK is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of OTRK (-32.47) is worse than 94.44% of its industry peers.
OTRK has a Debt/Equity ratio of 0.69. This is a neutral value indicating OTRK is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.69, OTRK is in line with its industry, outperforming 47.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -32.47 |
ROIC/WACCN/A
WACC5.5%
2.3 Liquidity
A Current Ratio of 1.17 indicates that OTRK should not have too much problems paying its short term obligations.
OTRK's Current ratio of 1.17 is on the low side compared to the rest of the industry. OTRK is outperformed by 67.59% of its industry peers.
OTRK has a Quick Ratio of 1.17. This is a normal value and indicates that OTRK is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of OTRK (1.17) is worse than 60.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
OTRK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.02%.
OTRK shows a decrease in Revenue. In the last year, the revenue decreased by -4.06%.
OTRK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.44% yearly.
EPS 1Y (TTM)-26.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.94%
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y-46.42%
Revenue growth 5Y-3.44%
Sales Q2Q%-30.94%
3.2 Future
Based on estimates for the next years, OTRK will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.91% on average per year.
OTRK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.13% yearly.
EPS Next Y86.79%
EPS Next 2Y38.89%
EPS Next 3Y24.94%
EPS Next 5Y14.91%
Revenue Next Year-18.59%
Revenue Next 2Y9.8%
Revenue Next 3Y23.24%
Revenue Next 5Y45.13%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
OTRK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OTRK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as OTRK's earnings are expected to grow with 24.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.89%
EPS Next 3Y24.94%
5. Dividend
5.1 Amount
OTRK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ONTRAK INC
NASDAQ:OTRK (12/20/2024, 8:00:02 PM)
1.44
-0.02 (-1.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners8.47%
Inst Owner Change-92.34%
Ins Owners0.58%
Ins Owner Change0%
Market Cap6.08M
Analysts82.86
Price Target4.08 (183.33%)
Short Float %1.26%
Short Ratio0.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.76%
Min EPS beat(2)-86.27%
Max EPS beat(2)-11.24%
EPS beat(4)1
Avg EPS beat(4)-22.41%
Min EPS beat(4)-86.27%
Max EPS beat(4)43.24%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.35%
Min Revenue beat(2)-7.58%
Max Revenue beat(2)-3.13%
Revenue beat(4)0
Avg Revenue beat(4)-6.86%
Min Revenue beat(4)-14.06%
Max Revenue beat(4)-2.69%
Revenue beat(8)0
Avg Revenue beat(8)-27.31%
Revenue beat(12)1
Avg Revenue beat(12)-21.31%
Revenue beat(16)4
Avg Revenue beat(16)-13.37%
PT rev (1m)-91.11%
PT rev (3m)33.33%
EPS NQ rev (1m)-1828.57%
EPS NQ rev (3m)-1828.57%
EPS NY rev (1m)-1.89%
EPS NY rev (3m)-1436.73%
Revenue NQ rev (1m)-39.25%
Revenue NQ rev (3m)-39.25%
Revenue NY rev (1m)-2.01%
Revenue NY rev (3m)-1.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.54 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.53 | ||
| P/tB | 1.06 | ||
| EV/EBITDA | N/A |
EPS(TTM)-10.62
EYN/A
EPS(NY)-4.13
Fwd EYN/A
FCF(TTM)-3.07
FCFYN/A
OCF(TTM)-3.02
OCFYN/A
SpS2.66
BVpS2.71
TBVpS1.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -159.29% | ||
| ROE | -311.45% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64% | ||
| FCFM | N/A |
ROA(3y)-156.54%
ROA(5y)-118.81%
ROE(3y)-473.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.4%
GM growth 5Y20.89%
F-Score4
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 8.06% | ||
| Cap/Sales | 1.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.17 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | -32.47 |
F-Score4
WACC5.5%
ROIC/WACCN/A
Cap/Depr(3y)46.16%
Cap/Depr(5y)46.03%
Cap/Sales(3y)5.19%
Cap/Sales(5y)3.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.94%
EPS Next Y86.79%
EPS Next 2Y38.89%
EPS Next 3Y24.94%
EPS Next 5Y14.91%
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y-46.42%
Revenue growth 5Y-3.44%
Sales Q2Q%-30.94%
Revenue Next Year-18.59%
Revenue Next 2Y9.8%
Revenue Next 3Y23.24%
Revenue Next 5Y45.13%
EBIT growth 1Y21.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y23.57%
EBIT Next 5Y22.03%
FCF growth 1Y66.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.04%
OCF growth 3YN/A
OCF growth 5YN/A